-
UBC9-Mediated SUMOylation of PINK1 Modulates Mitophagy in PD
2026-06-17
This study demonstrates that UBC9 regulates mitophagy and alleviates oxidative stress in Parkinson’s disease models via SUMOylation of PINK1. The findings clarify a mechanistic link between UBC9, PINK1 stability, and neuronal survival, suggesting UBC9 as a potential preventive target in PD progression.
-
JNK-IN-7: Precision Modulation of JNK Pathways in Apoptosis
2026-06-16
Explore how JNK-IN-7, a selective JNK inhibitor, enables targeted investigation of apoptosis and innate immune signaling. This cornerstone guide uniquely bridges mechanistic insight with advanced assay design for MAPK pathway research.
-
Nuclear cGAS Restricts L1 Retrotransposition via CHK2-TRIM41
2026-06-16
This study uncovers a key nuclear function of cGAS in repressing LINE-1 (L1) retrotransposition by promoting TRIM41-mediated degradation of L1-encoded ORF2p, a process dependent on CHK2-mediated phosphorylation of cGAS. These findings illuminate a previously underappreciated axis linking DNA damage response, genome stability, and retrotransposon control, with implications for aging and cancer biology.
-
Bacitracin (B1670): Technical Parameters for Antibacterial R
2026-06-15
Bacitracin (B1670) is a peptide antibiotic optimized for laboratory research targeting bacterial cell wall synthesis in both gram-positive and gram-negative bacteria. It is not intended for diagnostic or clinical use, and proper workflow setup is critical for reproducible results.
-
MLN2238 and the CRTC-CREB Axis: A New Era in Proteasome Rese
2026-06-15
Explore how MLN2238, a potent proteasome β5 subunit inhibitor, uniquely modulates the CRTC-CREB axis and redox responses. This article offers novel insights for oncology and proteostasis research, bridging molecular mechanisms with practical assay innovation.
-
Exemestane: Steroidal Aromatase Inhibitor for Breast Cancer
2026-06-14
Exemestane, a selective and irreversible steroidal aromatase inhibitor, empowers researchers to dissect estrogen biosynthesis and hormone-driven cancer pathways with high precision. Its robust inhibition profile and compatibility with advanced cell and tissue models make it indispensable for contemporary breast cancer research workflows.
-
Cytochalasin B: Precision Inhibitor for Cytoskeletal Researc
2026-06-13
Cytochalasin B (NSC 107658) revolutionizes cytoskeletal research by selectively disrupting actin dynamics, enabling high-fidelity interrogation of cell motility pathways and host-pathogen interactions. This guide synthesizes advanced protocols, real-world troubleshooting, and translational insights from landmark studies to help researchers maximize experimental reproducibility.
-
T0070907: A Next-Generation Tool for Dissecting PPARγ Pathwa
2026-06-12
Explore the advanced mechanistic and translational insights of T0070907, a potent PPARγ antagonist, in modulating PPARγ/RXRα signaling, adipogenesis, and cell cycle regulation. This article uniquely integrates cutting-edge findings on transcriptional repression with practical considerations for experimental design.
-
RESTRICT-seq Unveils KAT6A/B Dependencies in SCC Resistance
2026-06-12
The referenced study introduces RESTRICT-seq, a method for time-gated CRISPR screening, enabling the identification of previously unappreciated epigenetic dependencies in squamous cell carcinoma (SCC) resistance. Its innovative approach highlights the key role of KAT6A and KAT6B as epigenetic drug targets and provides a robust framework for dissecting oncogene-induced senescence mechanisms.
-
Pertussis Toxin: Optimizing Immune Modulation Assays in Rese
2026-06-11
Pertussis toxin, a potent AB5-type protein exotoxin, is a cornerstone for dissecting immune response modulation and cAMP signaling in translational immunology. This guide delivers actionable workflows, troubleshooting tactics, and evidence-driven protocol enhancements, connecting bench protocols to the latest breakthroughs in TH17 research.
-
CMA Decline in Skeletal Muscle Drives Age-Related Myopathy
2026-06-11
This study reveals that chaperone-mediated autophagy (CMA) activity declines with age in skeletal muscle, leading to impaired calcium handling and progressive myopathy. By employing innovative genetic models and in vivo reporters, the research clarifies CMA's essential role in muscle homeostasis, offering new directions for targeting age-related muscle degeneration.
-
MG-262 (Z-Leu-Leu-Leu-B(OH)2): Precision in Proteasome Inhib
2026-06-10
Explore how MG-262 (Z-Leu-Leu-Leu-B(OH)2) enables advanced proteasome inhibition studies and uniquely informs on BIRC2/BIRC3 regulation in cell signaling and apoptosis research. Gain deep scientific insights and practical assay guidance beyond standard protocols.
-
Deferoxamine Mesylate: Iron-Chelating Agent for Translationa
2026-06-10
Deferoxamine mesylate stands apart as an iron-chelating agent that not only suppresses iron-catalyzed oxidative stress and modulates HIF-1α but also enables precise modeling of hypoxia and ferroptosis for advanced cancer and tissue regeneration studies. This guide details optimized workflows, troubleshooting insights, and translational strategies, linking the latest mechanistic breakthroughs to actionable experimental design.
-
Advances in Oudemansiella raphanipies Polysaccharide Extract
2026-06-09
This study presents a systematic investigation into the extraction, structural characterization, functional properties, and oral absorption behavior of polysaccharides from Oudemansiella raphanipies. Optimized ultrasonic-assisted extraction and near-infrared fluorescence imaging reveal high bioactivity and promising prebiotic potential, informing future applications in functional foods and bioactive compound research.
-
ABCC10-Mediated cGAMP Efflux Drives Radiotherapy Resistance
2026-06-09
This study identifies the ATP-dependent transporter ABCC10 as a key mediator of 2'3'-cGAMP efflux in cancer cells, suppressing STING-mediated innate immune responses and contributing to radiotherapy resistance. Targeting ABCC10 may enhance radiosensitivity and inform the development of new biomarkers and therapeutic strategies.